Search research articles
Contact Us
Filters
Showing results (51-60 of 77) with videos related to
Page
of 8
Sort By:
Diabetes & Metabolism
|
November 26, 2018
Low N-terminal pro-brain natriuretic peptide levels are associated with non-alcoholic fatty liver disease in patients with type 2 diabetes
M L Johansen, M Schou, J Rasmussen, et al.
Atherosclerosis
|
May 9, 2023
Ventricular-arterial coupling (VAC) in a population-based cohort of middle-aged individuals: The STANISLAS cohort
H Holm, M Magnusson, A Jujić, et al.
The Journal of Clinical Investigation
|
June 20, 2001
LPS antagonism reduces graft-versus-host disease and preserves graft-versus-leukemia activity after experimental bone marrow transplantation
K R Cooke, A Gerbitz, J M Crawford, et al.
American Journal of Respiratory Cell and Molecular Biology
|
April 1, 1995
Induction of lipopolysaccharide-binding protein gene expression in cultured rat pulmonary artery smooth muscle cells by interleukin 1 beta
H R Wong, B R Pitt, G L Su, et al.
International Journal of Obesity (2005)
|
February 9, 2016
Galectin-3 inhibition prevents adipose tissue remodelling in obesity
E Martínez-Martínez, L Calvier, P Rossignol, et al.
International Journal of Cardiology
|
April 17, 2016
Neural modulation for hypertension and heart failure
S Smith, P Rossignol, S Willis, et al.
International Journal of Cardiology
|
March 13, 2017
Combined baseline and one-month changes in big endothelin-1 and brain natriuretic peptide plasma concentrations predict clinical outcomes in patients with left ventricular dysfunction after acute myocardial infarction: Insights from the Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study (EPHESUS) study
A Olivier, N Girerd, J B Michel, et al.
Surgery
|
August 1, 1994
Suppression of lipopolysaccharide-induced macrophage nitric oxide and cytokine production in vitro by a novel lipopolysaccharide antagonist
S C Wang, D P Rossignol, W J Christ, et al.
Steroids
|
June 2, 2009
Saliva as a medium for aldosterone measurement in repeated sampling studies
J Manolopoulou, P Mulatero, C Maser-Gluth, et al.
Antimicrobial Agents and Chemotherapy
|
February 19, 2000
Consequences of interaction of a lipophilic endotoxin antagonist with plasma lipoproteins
J R Rose, M A Mullarkey, W J Christ, et al.
Page
of 8
Search research articles
Search
Showing results (51-60 of 77) with videos related to
Sort By:
Page
of 8
Diabetes & Metabolism
|
November 26, 2018
Low N-terminal pro-brain natriuretic peptide levels are associated with non-alcoholic fatty liver disease in patients with type 2 diabetes
M L Johansen, M Schou, J Rasmussen, et al.
Atherosclerosis
|
May 9, 2023
Ventricular-arterial coupling (VAC) in a population-based cohort of middle-aged individuals: The STANISLAS cohort
H Holm, M Magnusson, A Jujić, et al.
The Journal of Clinical Investigation
|
June 20, 2001
LPS antagonism reduces graft-versus-host disease and preserves graft-versus-leukemia activity after experimental bone marrow transplantation
K R Cooke, A Gerbitz, J M Crawford, et al.
American Journal of Respiratory Cell and Molecular Biology
|
April 1, 1995
Induction of lipopolysaccharide-binding protein gene expression in cultured rat pulmonary artery smooth muscle cells by interleukin 1 beta
H R Wong, B R Pitt, G L Su, et al.
International Journal of Obesity (2005)
|
February 9, 2016
Galectin-3 inhibition prevents adipose tissue remodelling in obesity
E Martínez-Martínez, L Calvier, P Rossignol, et al.
International Journal of Cardiology
|
April 17, 2016
Neural modulation for hypertension and heart failure
S Smith, P Rossignol, S Willis, et al.
International Journal of Cardiology
|
March 13, 2017
Combined baseline and one-month changes in big endothelin-1 and brain natriuretic peptide plasma concentrations predict clinical outcomes in patients with left ventricular dysfunction after acute myocardial infarction: Insights from the Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study (EPHESUS) study
A Olivier, N Girerd, J B Michel, et al.
Surgery
|
August 1, 1994
Suppression of lipopolysaccharide-induced macrophage nitric oxide and cytokine production in vitro by a novel lipopolysaccharide antagonist
S C Wang, D P Rossignol, W J Christ, et al.
Steroids
|
June 2, 2009
Saliva as a medium for aldosterone measurement in repeated sampling studies
J Manolopoulou, P Mulatero, C Maser-Gluth, et al.
Antimicrobial Agents and Chemotherapy
|
February 19, 2000
Consequences of interaction of a lipophilic endotoxin antagonist with plasma lipoproteins
J R Rose, M A Mullarkey, W J Christ, et al.
Page
of 8